If this is your company, CONTACT US to activate Packbase™ software to build your portal.


Sanofi and Boehringer Ingelheim today have entered into exclusive negotiations to swap businesses. The proposed transaction would consist of an exchange of Sanofi animal health business (Merial) with an enterprise value of €11.4 bn and Boehringer Ingelheim consumer healthcare (CHC) business with an enterprise value of €6.7 bn. Boehringer Ingelheim CHC business in China would be excluded from the transaction. The transaction would also include a gross cash payment from Boehringer Ingelheim to Sanofi of €4.7 bn.
Sanofi would become a global leader in consumer healthcare and Boehringer Ingelheim would become second largest animal health company.
